関連する実験動画
Updated: Jun 23, 2026
10:14
Recapitulation of an Ion Channel IV Curve Using Frequency Components
Published on: February 9, 2011
ミュータントカベオリン-3は持続的な遅いナトリウム電流を誘発し,長QT症候群と関連しています
Matteo Vatta1, Michael J Ackerman, Bin Ye
1Department of Pediatrics (Cardiology), Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA. mvatta@bcm.tmc.edu
Circulation
|October 25, 2006
まとめ
カベオリン-3 (CAV3) の変異は,遅いナトリウム電流を増加させることで,長QT症候群 (LQTS) を引き起こします. この発見は,LQTSと突然の心臓死の原因となる新しい遺伝的原因を特定しています.
科学分野:
- 心血管遺伝学 心血管遺伝学
- 分子心臓病学 分子心臓病学
- イオンチャネル病変はイオンチャネル病変である.
背景:
- 生まれながらの長QT症候群 (LQTS) は,心臓の再極化に影響を与える主要なリズム障害であり,約3000人に1人の突然死を引き起こす.
- 多くのLQTS感受性遺伝子が知られているが,約25%の症例は説明がつかないままである.
- 心臓のナトリウムチャネル (SCN5A) は,キャベオラに局所化し,キャベオリン-3が豊富で,キャベオリン-3が潜在的なLQTS遺伝子であることを示唆しています.
研究 の 目的:
- LQTS.の新たな遺伝的原因として,カベオリン-3 (CAV3) の変異を調査する.
- 特定されたCAV3変異が心臓のナトリウムチャネル活動に及ぼす機能的影響を決定する.
主な方法:
- PCR,DHPLC,DNAシーケンシングを用いた905人のLQTS患者におけるCAV3の遺伝子解析.
- CAV3変異を設計するためのサイト指向型変異.
- HEK293細胞における異質的発現は,突然変異したカヴェオリン-3が心臓のナトリウムチャネル (hNa(v) 1.5機能に与える影響を評価するためである.
主要な成果:
- LQTS患者では4つの新しいCAV3変異が特定され,対照群には存在しなかった.
- 変異したカヴェオリン-3は,hNaを発現する細胞で,遅いナトリウム電流 (2〜3倍) を有意に増加させた1.5.5.v)
- このナトリウム電流に対する機能増強効果は,LQT3に関連したSCN5A変異に見られるものに似ています.
結論:
- この研究は,LQTSと関連した最初の特定されたCAV3変異を報告しています.
- CAV3の変異は,遅いナトリウム電流で機能の獲得につながり,LQTSのための新しい病原性メカニズムを確立します.
関連する概念動画
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...